background: acute pancreatitis is a common complication of endoscopic retrograde cholangiopancreatography (ercp). several medical and surgical procedures have been analyzed in prevention of post-ercp pancreatitis as a major post-ercp complication, so we conducted a study to assess the role of prophylactic pancreatic stents on prevention and severity of post-ercp pancreatitis. materials and meth...

the invention of the drug-eluting stent (des) has brought about revolutionary changes in the field of interventional cardiology. in the des era, in-stent restenosis has declined but new issues such as stent thrombosis have emerged. one of the emerging paradigms in the des era is stent fracture. there are reports about stent fracture leading to in-stent restenosis or stent thrombosis. most of th...

Remo Albiero, Milena Adamian, Nobuyuky Kobayashi, Antonio Amato, Marco Vaghetti, Carlo in Patients With Coronary Artery Disease : The Milan Dose-Response Study -Emitting Stent Implantation β P Radioactive 32 Shortand Intermediate-Term Results of Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2000 American Heart Association, Inc. All rights reserved. is published by the American Heart...

Introduction: This study aimed to evaluate the effects of four-time inflation of the stent balloon at nominal pressure on optimal stent expansion in resistant lesions. Materials and Methods: This interventional study was conducted on 39 patients with coronary artery lesions, in whom Zotarolimus-eluting stents (N=20), Paclitaxel-eluting stents (N=11) and other stents (N=8) were deployed four tim...

background: the biolimus-eluting stent (bes), with a biodegradable polymer, has not been previously compared with the everolimus-eluting stent (ees), as a second-generation drug-eluting stent (des).we sought to compare the 1-year outcome between the promus ™ stent (ees type) and the biomatrix ™ stent (bes type). methods: from march 2008 to september 2011, all patients treated with the promus™ s...